If you thought the FDA’s Human Foods Program (HFP) spent 2025 just rearranging labels and scolding salt shakers, think again. In 2026, the agency is showing up with a color-coded spreadsheet, a microscope, and a very strong opinion about what’s in America’s pantry.
This is the year the FDA leans all the way into Making America Healthy Again (MAHA)—with food as both the problem and the solution. Translation for regulated businesses: the era of “we’ve always done it this way” is over, and the era of “please show your work” has arrived.
Here’s what’s coming, why it matters, and how to make sure your company isn’t the example everyone else quietly learns from.
Chemicals, Colors, and the End of the GRAS Free-for-All
GRAS Reform: “We Assessed It Ourselves” Is No Longer Enough
For years, “Generally Recognized as Safe” has operated more as a flexible convention than a rigorously enforced regulatory standard. Companies could self-affirm GRAS status, skip FDA review, and move on—often without much daylight on how the conclusion was reached. That era is ending.
In 2026, FDA plans to require mandatory submission of GRAS notices for all new substances, closing the loophole that allowed ingredients to enter the food supply without FDA ever seeing the safety rationale. Self-affirmation without oversight is officially out of fashion.
What this means for industry:
- Conduct a full inventory of ingredients and GRAS determinations
- Flag substances relying on legacy science or informal reasoning
- Develop defensible, well-documented safety dossiers grounded in current data
In other words, if your compliance plan depends on silence and plausible deniability, it’s time for a new plan.
Post-Market Chemical Reviews: The Audit Has Entered the Chat
Phthalates, BHA, BHT, propylparaben—if it’s sparked consumer concern or a viral thread, chances are FDA is already taking a closer look. In 2026, HFP is formalizing a systematic post-market assessment process, bringing greater transparency, public input, and a clearer explanation of how food chemicals are selected, evaluated, and—if necessary—restricted.
What this means for industry:
- Treat legacy ingredients as fully reviewable, not grandfathered
- Pressure-test safety justifications using current science
- Be ready for reformulation discussions that begin with “out of an abundance of caution…”
Microplastics: Yes, Even Those
Microplastics are officially on FDA’s scientific radar. In 2026, HFP will develop validated methods to detect and measure them in food.
Translation: If your packaging, processing, or sourcing could introduce microplastics, FDA wants to know—and eventually, so will consumers.
Colors: Artificial is Out, Nature Is In
Artificial colors are being phased out, replaced by natural alternatives. FDA is expediting reviews of natural color additives and clarifying when fruit and vegetable juices count as colors (and when they don’t).
Industry reality check:
- Reformulation timelines should start yesterday
- Natural colors come with stability, supply, and cost challenges—plan accordingly
- “Natural-ish” will not cut it
Nutrition Gets Serious (and Front-of-Package Gets Loud)
Ultra-Processed Foods: Define, Then Tame
FDA is working with USDA to develop a federal definition of ultra-processed foods (UPFs). Once defined, expect policy, labeling, and reformulation pressure to follow.
If you sell UPFs:
- Start scenario planning now
- Track sugar, sodium, and additive profiles
- Prepare for consumer-facing scrutiny, not just regulatory review
Front-of-Package Labeling: The Billboard Era
Front-of-package (FOP) labeling is moving from proposal to decision-making. Added sugar and sodium will no longer hide on the back panel in 6-point font.
What smart companies are doing:
- Mocking up FOP labels early
- Modeling reformulation impacts
- Coordinating regulatory, marketing, and R&D teams (yes, all three)
The “Healthy” Claim: Earned, Not Assumed
FDA is reassessing the “healthy” claim to align with current dietary guidelines and may introduce a standardized symbol.
Heads up: If your product wears the “healthy” badge, FDA wants proof—and may change the rules midstream.
Sugar and Sodium: The Long Goodbye
Added sugar reduction strategies and sodium targets are advancing. Phase I sodium targets already reduced intake by ~10%, and FDA is evaluating what comes next.
Industry move: Treat voluntary targets as pre-mandatory. History suggests that’s how this movie ends.
Babies, Supplements, and Caffeine Chaos
Infant Formula: Operation Stork Speed, Continued
FDA is modernizing infant formula nutrient requirements for the first time in decades, while releasing new contaminant exposure data.
For formula manufacturers:
- Expect science-heavy scrutiny
- Expect zero tolerance for quality lapses
- Expect FDA to move faster than it used to
Dietary Supplements: DSHEA Gets a Midlife Crisis
With exploding supplement sales, FDA is modernizing oversight. Final guidance on New Dietary Ingredients (NDIs) is coming, along with streamlined (but firmer) review processes.
Key message: Growth does not excuse noncompliance. If your NDI file is thin, FDA will notice.
Caffeine Labeling: Say It Loud, Say It Clear
Added caffeine labeling best practices are coming—for packaged foods and restaurants.
If your product is quietly caffeinated, it won’t be for long.
Inspections, Imports, and Traceability (aka “Where Did This Come From?”)
BRIDGE: More State Inspectors, Same FDA Expectations
FDA will increasingly rely on trained state partners for routine inspections, freeing federal resources for high-risk and foreign facilities.
Important note:
This is not “lighter” oversight—it’s more coverage. Your compliance game must travel well across jurisdictions.
Imports and Seafood: No More Weak Links
Enhanced analytics, AI-driven screening, and deeper partnerships (especially with Mexico, India, and Ecuador) are coming for imported foods—particularly seafood.
Importers should:
- Audit foreign supplier verification programs
- Prepare for more data-driven scrutiny
- Expect less patience for repeat violations
Food Traceability: Practice Makes Prepared
FDA is running tabletop exercises and stakeholder education to ensure readiness for the Food Traceability Rule.
If you’re covered:
- Test your systems now
- Train staff beyond “the traceability person”
- Assume FDA will ask for records on a bad day
The Big Picture: Transparency Is the New Baseline
Across chemicals, nutrition, inspections, and recalls, one theme dominates 2026: visibility. FDA wants to see what’s in food, how it got there, and why you think it’s safe. Consumers want the same thing—just in fewer syllables and bigger fonts.
What Regulated Businesses Should Be Doing Right Now
- Audit ingredients, claims, and labels with 2026 eyes
- Invest in regulatory intelligence, not just regulatory reaction
- Break silos between compliance, R&D, and marketing
- Plan reformulation strategically, not defensively
- Document everything—because FDA will ask
Final Bite
FDA’s 2026 agenda signals a shift from minimal compliance to meaningful accountability. The winners will be the companies that plan for it.
In other words: the future of food isn’t just healthier. It’s better documented.
For more information on FDA’s 2026 priorities, and FDA food compliance and enforcement, please email info@garg-law.com.
